Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Audiologist's Role in Determining Cochlear Function After Gunshot Injury to the Temporal Bone.

American journal of audiology·2025
Same author

Critical Thinking: A Program Review of Doctor of Audiology Students.

American journal of audiology·2023
Same author

A Program Review of Head Start and Elementary School Hearing Screenings.

Language, speech, and hearing services in schools·2020
Same author

Letter to the Editor: An Affront to Scientific Inquiry Re: Moore, D. R. (2018) Editorial: Auditory Processing Disorder, Ear Hear, 39, 617-620.

Ear and hearing·2018
Same author

Delayed diagnosis of a patient with Usher syndrome 1C in a Louisiana Acadian family highlights the necessity of timely genetic testing for the diagnosis and management of congenital hearing loss.

SAGE open medical case reports·2017
Same author

Detailed Audiological Evaluation of a Patient with Xeroderma Pigmentosum with Neural Degeneration.

Journal of the American Academy of Audiology·2017
Same journal

Psychometric Rigor Before Clinical or Research Implementation.

Journal of the American Academy of Audiology·2026
Same journal

American Academy of Audiology Health-Related Quality of Life Benefits of Amplification for Adults with Sensorineural Hearing Loss: A Systematic Review Protocol.

Journal of the American Academy of Audiology·2026
Same journal

Evidence Synthesis and Open Science: A Tutorial for Systematic Reviews and Beyond in Audiology Research.

Journal of the American Academy of Audiology·2026
Same journal

State and Trait Anxiety Alter Postural Control in Healthy Adults.

Journal of the American Academy of Audiology·2026
Same journal

Differentiating Superior and Inferior Vestibular Neuritis: Insights from an Integrated VEMP and vHIT Assessment.

Journal of the American Academy of Audiology·2026
Same journal

Test-Retest Reliability of the Triangle Completion Test.

Journal of the American Academy of Audiology·2026
See all related articles

Related Experiment Videos

Evaluating a model to predict protocol performance.

Robert G Turner1, Annette Hurley

  • 1Department of Communication Disorders, Louisiana State University Health Sciences Center, USA. rturne@lsuhsc.edu

Journal of the American Academy of Audiology
|May 28, 2010
PubMed
Summary
This summary is machine-generated.

A new mathematical model accurately predicts test protocol performance, even with incomplete clinical data. This tool aids clinicians in selecting the best protocol from many options.

Related Experiment Videos

Area of Science:

  • Medical Informatics
  • Clinical Decision Support Systems
  • Biostatistics

Background:

  • Selecting optimal test protocols from numerous combinations can be challenging for clinicians.
  • Lack of performance data for potential protocols complicates clinical decision-making.
  • A predictive model could significantly improve protocol selection efficiency.

Purpose of the Study:

  • To assess the predictive accuracy and validity of a novel mathematical model for clinical test protocol performance.
  • To determine the model's utility in guiding protocol selection under varying data availability.

Main Methods:

  • Model predictions were systematically compared against empirical data from actual test protocol performance.
  • The study evaluated model accuracy using both complete and incomplete information datasets.

Main Results:

  • Near-perfect agreement was observed between predicted and actual protocol performance when complete data was available.
  • The model demonstrated high accuracy in estimating protocol performance even with partial or missing information.

Conclusions:

  • The mathematical model effectively predicts test protocol performance, proving valuable even with incomplete clinical data.
  • This predictive tool can help clinicians narrow down protocol choices and select the most appropriate option.
  • The model enhances clinical decision-making by providing reliable performance estimates for test protocols.